[go: up one dir, main page]

WO2003041703A3 - Use of a flavonoid for the treatment of burns - Google Patents

Use of a flavonoid for the treatment of burns Download PDF

Info

Publication number
WO2003041703A3
WO2003041703A3 PCT/NL2002/000742 NL0200742W WO03041703A3 WO 2003041703 A3 WO2003041703 A3 WO 2003041703A3 NL 0200742 W NL0200742 W NL 0200742W WO 03041703 A3 WO03041703 A3 WO 03041703A3
Authority
WO
WIPO (PCT)
Prior art keywords
burns
flavonoid
treatment
present
burn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL2002/000742
Other languages
French (fr)
Other versions
WO2003041703A2 (en
Inventor
Conradus Ghosal Gho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GHO HOLDING BV
Original Assignee
GHO HOLDING BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GHO HOLDING BV filed Critical GHO HOLDING BV
Publication of WO2003041703A2 publication Critical patent/WO2003041703A2/en
Publication of WO2003041703A3 publication Critical patent/WO2003041703A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is concerned with a new method of treating burns. More particularly the present invention relates to a method of treating a mammal suffering from a burn, which method comprises administering to said mammal a quercetin analogue in a therapeutically effective amount to prevent secondary injury of tissue that was not directly affected by the initial burn.
PCT/NL2002/000742 2001-11-16 2002-11-15 Use of a flavonoid for the treatment of burns Ceased WO2003041703A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204382 2001-11-16
EP01204382.4 2001-11-16

Publications (2)

Publication Number Publication Date
WO2003041703A2 WO2003041703A2 (en) 2003-05-22
WO2003041703A3 true WO2003041703A3 (en) 2003-07-31

Family

ID=8181248

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2002/000742 Ceased WO2003041703A2 (en) 2001-11-16 2002-11-15 Use of a flavonoid for the treatment of burns

Country Status (1)

Country Link
WO (1) WO2003041703A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2010222C2 (en) 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells.
NL2010225C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for preserving, transporting and storing living biological materials.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466961A (en) * 1981-03-17 1984-08-21 Human Oltoanyagtermeloo es Kutato Intezet Composition for the treatment of epithelial injuries and process for the preparation thereof
EP0648496A1 (en) * 1993-10-15 1995-04-19 Bristol-Myers Squibb Company Therapeutic compositions for use in the treatment of skin lesions and method of making same
JPH07277939A (en) * 1994-04-05 1995-10-24 Dowa Mining Co Ltd Skin external preparation
WO1999006056A1 (en) * 1997-07-29 1999-02-11 Gho'st Holding B.V. Use of physiologically acceptable vanadium compounds, salts and complexes
US6203818B1 (en) * 1997-03-20 2001-03-20 Coventry Group, Ltd. Nutritional supplement for cardiovascular health
JP2001200238A (en) * 2000-01-19 2001-07-24 Pokka Corp Uv absorbing agent and skin agent for external use containing it
EP1136073A1 (en) * 2000-03-22 2001-09-26 N.V. Nutricia Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466961A (en) * 1981-03-17 1984-08-21 Human Oltoanyagtermeloo es Kutato Intezet Composition for the treatment of epithelial injuries and process for the preparation thereof
EP0648496A1 (en) * 1993-10-15 1995-04-19 Bristol-Myers Squibb Company Therapeutic compositions for use in the treatment of skin lesions and method of making same
JPH07277939A (en) * 1994-04-05 1995-10-24 Dowa Mining Co Ltd Skin external preparation
US6203818B1 (en) * 1997-03-20 2001-03-20 Coventry Group, Ltd. Nutritional supplement for cardiovascular health
WO1999006056A1 (en) * 1997-07-29 1999-02-11 Gho'st Holding B.V. Use of physiologically acceptable vanadium compounds, salts and complexes
JP2001200238A (en) * 2000-01-19 2001-07-24 Pokka Corp Uv absorbing agent and skin agent for external use containing it
EP1136073A1 (en) * 2000-03-22 2001-09-26 N.V. Nutricia Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MENG, DESHENG ET AL: "Protective effects of quercetin, rutoside, and flavone against intestinal mucosal injury induced by burns in mice", XP002195800, retrieved from STN Database accession no. 135:147358 *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 02 29 February 1996 (1996-02-29) *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 24 11 May 2001 (2001-05-11) *
ZHONGGUO YAOLIXUE TONGBAO (2000), 16(6), 673-675 *

Also Published As

Publication number Publication date
WO2003041703A2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
WO2001087328A3 (en) Interleukin-1 inhibitors in the treatment of diseases
WO2002017914A8 (en) Fused pyrrolocarbazoles against inflammation
WO2003000241A3 (en) Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases
WO2002058734A3 (en) Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
DK1411932T3 (en) Combination therapy with substituted oxazolidinones
ATE492279T1 (en) BUPROPINE METABOLITES FOR THE TREATMENT OF DEMENTIA AND OTHER CEREBROVACCULAR DISEASES
CY1105199T1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF MUCUS DISCHARGE
WO2003014309A3 (en) Interleukin-1 receptors in the treatment of diseases
GB0001449D0 (en) Compositions
DE60219614D1 (en) 3, 7 THIAPROSTANSÄUREDERIVATE AS A MEANS FOR THE REDUCTION OF THE AUGENINNENDRUCKES
WO1999045920A3 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
WO2003037368A3 (en) Smad7 inhibitors for the treatment of cns diseases
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
WO2001024783A3 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
BG105953A (en) METHOD FOR TREATMENT OF CHRONIC OBSTRUCTIVE BENEFITAL DISEASE
BR0017158A (en) 5ht2 Agonists to Control Iop and Treat Glaucoma
MXPA02011921A (en) INHIBITORS OF DIPEPTIDASE ACID N-ACETILATED-ALPHA-LINKED FOR THE TREATMENT OF RETINIAN DISORDERS AND GLAUCONA.
NZ519722A (en) Treatment of diabetic ulcers
WO2002096855A3 (en) Anticholinergic compounds and methods of use
WO2003041703A3 (en) Use of a flavonoid for the treatment of burns
WO2003053352A3 (en) Therapeutic compounds for treating dyslipidemic conditions
WO2002072105A3 (en) Improved prostanoid therapies for the treatment of glaucoma

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A DATED 28-07-2004).

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP